Tyrosine Kinase Inhibitors EGFR Immunotherapy CD Protein Inhibitors Immune Checkpoint Inhibitors Other | Non Small Cell Lung Cancer | Lung Adenocarcinoma | Gastric Cancer | Biliary Tract Cancer | Solid Tumor |
---|---|---|---|---|---|
tepotinib | |||||
crizotinib | |||||
cabozantinib tablet | |||||
capmatinib | |||||
savolitinib | |||||
REGN5093 | |||||
BPI-9016M | |||||
amivantamab-vmjw | |||||
ABN401 | |||||
SCC244 | |||||
nivolumab | |||||
CKD-702 | |||||
DO-1 | |||||
tepotinib + capmatinib | |||||
pembrolizumab | |||||
APL-101 | |||||
ensartinib | |||||
GB263T | |||||
KC1036 | |||||
durvalumab | |||||
S95027 | |||||
PD1 inhibitor | |||||
c-MET inhibitor | |||||
c-MET inhibitor + Tyrosine kinase inhibitor | |||||
Immunotherapy |